Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Diamond J. P. Treatable blindness in temporal arteritis. Br J Ophthalmol. 1991 Jul;75(7):432–432. doi: 10.1136/bjo.75.7.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graham E., Holland A., Avery A., Russell R. W. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):269–271. doi: 10.1136/bmj.282.6260.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Model D. G. Reversal of blindness in temporal arteritis with methylprednisolone. Lancet. 1978 Feb 11;1(8059):340–340. doi: 10.1016/s0140-6736(78)90126-5. [DOI] [PubMed] [Google Scholar]
- Rosenfeld S. I., Kosmorsky G. S., Klingele T. G., Burde R. M., Cohn E. M. Treatment of temporal arteritis with ocular involvement. Am J Med. 1986 Jan;80(1):143–145. doi: 10.1016/0002-9343(86)90066-5. [DOI] [PubMed] [Google Scholar]
- Slavin M. L., Margolis A. J. Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous corticosteroids. Arch Ophthalmol. 1988 Sep;106(9):1167–1167. doi: 10.1001/archopht.1988.01060140327015. [DOI] [PubMed] [Google Scholar]
- Thompson J. F., Chalmers D. H., Wood R. F., Kirkham S. R., Morris P. J. Sudden death following high-dose intravenous methylprednisolone. Transplantation. 1983 Nov;36(5):594–596. [PubMed] [Google Scholar]